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The resistance of Pseudomonas aeruginosa to conventional antimicrobial treatment is a
major scourge in healthcare. Therefore, it is crucial that novel potent anti-infectives are
discovered. The aim of the present study is to screen marine actinomycetes for chemical
entities capable of overcoming P. aeruginosa infection through mechanisms involving
anti-virulence or host immunity activities. A total of 18 actinomycetes isolates were
sampled from marine sediment of Songsong Island, Kedah, Malaysia. Upon confirming
that the methanolic crude extract of these isolates do not display direct bactericidal
activities, they were tested for capacity to rescue Caenorhabditis elegans infected
with P. aeruginosa strain PA14. A hexane partition of the extract from one isolate,
designated as Streptomyces sp. CCB-PSK207, could promote the survival of PA14
infected worms by more than 60%. Partial 16S sequence analysis on this isolate showed
identity of 99.79% with Streptomyces sundarbansensis. This partition did not impair
feeding behavior of C. elegans worms. Tested on PA14, the partition also did not affect
bacterial growth or its ability to colonize host gut. The production of biofilm, protease,
and pyocyanin in PA14 were uninterrupted, although there was an increase in elastase
production. In lys-7::GFP worms, this partition was shown to induce the expression
of lysozyme 7, an important innate immunity defense molecule that was repressed
during PA14 infection. GC-MS analysis of the bioactive fraction of Streptomyces sp.
CCB-PSK207 revealed the presence of methyl esters of branched saturated fatty acids.
In conclusion, this is the first report of a marine actinomycete producing metabolites
capable of rescuing C. elegans from PA14 through a lys-7 mediated activity.
Keywords: Caenorhabditis elegans, Pseudomonas aeruginosa, marine actinomycetes, Streptomyces sp.,
lysozyme 7
INTRODUCTION
Pseudomonas aeruginosa, an opportunistic human pathogen is a principal cause of nosocomial
infection, leading to morbidity and mortality in immune-compromised patients (Moy et al., 2006;
Driscoll et al., 2007). Among dangers posed by P. aeruginosa is healthcare associated pneumonia
and infection of burn patients (Rello et al., 2003; Agodi et al., 2007). The perilous emergence
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of multidrug resistant P. aeruginosa strains is hindering the
development and effectiveness of antibiotics (Hauser and Sriram,
2005; Levy, 2005; Aloush et al., 2006). To circumvent problems
associated with antibiotic resistance, the search for new anti-
infectives targeting bacterial virulence or host immunity have
gained momentum (Clatworthy et al., 2007; Hancock et al.,
2012). In comparison to traditional antibiotics which exert
their effects through bactericidal activities, anti-infectives do
not contribute to selection pressure which unwantedly leads to
resistance development (Hamill et al., 2008).
The nematode Caenorhabditis elegans is readily infected
with numerous human bacterial pathogens and amenable
to various molecular tools, making it a reliable model for
understanding different facets host–pathogen interaction such as,
virulence factors and innate immunity pathways (Aballay and
Ausubel, 2002). These attributes, coupled with a high degree of
conservation with human innate immune signaling pathways,
promote the use of C. elegans for drug discovery (Artal-Sanz
et al., 2006; Burns et al., 2006). The co-existence of both pathogen
and host in a host-pathogen relationship provides the capacity
of identifying chemical entities capable of rescuing infected host.
Academically, this may lead to the discovery of molecules that
attenuate bacterial virulence or augment the immunity of the
host (Moy et al., 2006). The use of C. elegans as in host-pathogen
screening assays have been extended to many human pathogens,
including Enterococcus faecalis (Moy et al., 2006), Candida
albicans (Breger et al., 2007), Vibrio alginolyticus (Durai et al.,
2013), Staphylococcus aureus (Kong et al., 2014b), Burkholderia
pseudomallei (Eng and Nathan, 2015), and Salmonella enteritidis
(Kulshreshtha et al., 2016).
Actinomycetes are persistent soil inhabitants with exceptional
capacity to produce clinically useful secondary metabolites,
having contributed to more than 50% of the microbial antibiotics
discovered (Bérdy, 2005). Early efforts in actinomycetes drug
discovery concentrated mostly on soil isolates, due to the
erroneous view that the marine environment is a poor source
for this group of bacteria (Fenical and Jensen, 2006). However,
the diversity of the marine environment enforces a natural
selection toward an immeasurable pool of microbial secondary
metabolites and may therefore offers a rich and yet unexploited
source of actinomycetes, with representatives reported from
seawater, intertidal zones, ocean floor, deep ocean trenches,
ocean sediments, invertebrates, and plants (Bull et al., 2005). As
result, a promising number of novel secondary metabolites with
biological properties are constantly being reported from marine
actinomycetes (Feling et al., 2003; Lam, 2006; Solanki et al., 2008;
Kang et al., 2015). Compounds originating frommarinemicrobes
that attenuate virulence through inhibition of quorum sensing
system without bacteriocidal activities have also been reported
(Fu et al., 2013; Naik et al., 2013).
The C. elegans-PA14 relationship has been used to screen
natural products from terrestrial plants, endophytic fungi,
marine bacteria, and seaweeds, to search for compounds capable
of boosting immunity of PA14 infected worms or diminishing
quorum sensing and virulence factors (Zhou et al., 2011;
Dharmalingam et al., 2012; Kandasamy et al., 2012; Liu et al.,
2013). Elsewhere, single compounds such as, curcumin and
selenium were also reported to protect C. elegans during
PA14 infection (Rudrappa and Bais, 2008; Li et al., 2014).
Given the vast potential of marine actinomycetes as source of
secondary metabolites and the robustness of the C. elegans-
PA14 screening assay, we utilized the assay to screen for marine
actinomycetes capable of producing metabolites that extend the
lifespan of infected worms. An extract from Streptomycetes sp.,
conferred survival advantage to the PA14 infected C. elegans
with a host-directed mechanism partially mediated by the up-
regulation of lys-7 gene. Major compounds in the bioactive
fraction were identified as methyl esters of several saturated fatty
acids.
MATERIALS AND METHODS
Bacteria and Worms
PA14 and Escherichia coli strain OP50 were cultured as
described previously (Dharmalingam et al., 2012). C. elegans
strain CF4059 with genotype fer-15(b26)II; rol-6(su1006)II; fem-
1(hc17)IV which is sterile at 25◦C and of the roller phenotype
to avoid confounding progeny production during screening and
aid in worm scoring were obtained from Cynthia Kenyon Lab
(University of California, USA). C. elegans strain SAL105 with
genotype pha-1(e2123) III;denEx2 whose lys-7 gene was tagged
with green fluorescent protein (Alper et al., 2007) were obtained
from Caenorhabditis Genetics Center (CGC), USA (https://cbs.
umn.edu/cgc/home), respectively. Procedures for maintenance
and handling of all worms were approved by the Universiti Sains
Malaysia Animal Ethics Committee.
Microbial Sample Collection
A total of 10 sea bed soil samples were collected from waters
at depths ranging from 10 to 20m deep from Songsong Island,
Yan, Kedah, Malaysia (5◦48′37.2′′N 100◦17′47.5′′E) on December
2013. The sediment samples were spread on petri plates and dried
overnight in laminar flow hood (Valli et al., 2012).
Isolation of Actinomycetes
After drying, samples were heated at 70 ± 2◦C for 15min
and were grinded lightly with alcohol-sterilized mortar and
pestle. Ten-fold serial dilution up to 10−5 was carried out by
diluting 1.0 g of sediment sample in 9.0mL of 50% artificial
sea water (ASW). Approximately, 0.1mL of the mixture was
spread on starch casein agar (SCA) supplemented with 80 µg
mL−1of cycloheximide. All plates were incubated at 28 ± 2◦C
and observed for actinomycetes growth for 28 days (Mincer
et al., 2002; Valli et al., 2012). Grown colonies were observed for
morphological differences and listed as candidates for screening
assays.
Preparation of Actinomycetes Extracts
The isolates were cultured in M1 medium [ingredients: 10.0 g
soluble starch, 4.0 g yeast extract, 2.0 g peptone, and 1.0 L
distilled water followed by autoclaving at 121◦C for 20min] and
incubated with shaking at 28 ± 2◦C, 200 rpm for 7–14 days.
The culture broth was freeze-dried and extracted with 1:100
(w/v) methanol (MeOH). The mixture was shaken overnight
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and then filtered using Whatman grade 1 cellulose filter paper
with 11µM pore size. The filtrate was concentrated using rotary
evaporator at 60 ± 2◦C. The extracts were stored at −20
± 2◦C and adjusted to working concentration with distilled
water.
Anti-microbial Assay
Anti-bacterial screening of extracts was performed using the
modified Kirby-Bauer disc diffusion method. A few colonies
of P. aeruginosa PA14 from a culture plate incubated for 24 h
were directly inoculated in 0.85% saline. The suspension was
compared to a 0.5 McFarland turbidity standard and adjusted
with sterile saline. A sterile cotton swab was dipped into the
suspension and pressed on the wall of tubes to remove excess
bacterial suspension. The swab was repeatedly streaked over the
entire surface of Mueller-Hinton agar (Merck, Germany) until
the entire surface was streaked. A sterileWhatman antibiotic disc
with a 6mm diameter was placed on the bacterial lawn and 10µL
of 200µgmL−1 crude extract was transferred onto each disc. The
plates were inverted and incubated at 37± 2◦C for 24 h. The zone
of inhibition was measured and recorded after the incubation
period.
Slow Killing Survival Assay
For the survival assay, C. elegans strain CF4059 was used. Young
adult worms were age-synchronized and infected with PA14
on Pseudomonas Infection agar (PIA) as described previously
(Dharmalingam et al., 2012). Final concentration of extract in
each plate was 200 µg mL−1 while a negative control plate
contained only distilled water. Worm survival was scored every
24 h, with mortality designated as failure of worm to react by
motion when prodded with platinum wire (Powell and Ausubel,
2008). A total time of 96 h was selected as the screening time-
point as it gave the best resolution in identifying a potent hit
candidate. Worms that crawled onto the plate wall were not
included in the final survival analysis.
Molecular Characterization of Bacterial
Isolate
The isolate which produced extract contributing to highest
worm survival in the slow killing survival assay described above
was cultured in M1 broth for 5 days at 180 rpm at 28 ±
2◦C. Genomic DNA of the isolate was extracted using Real
Biotech Corporation Hi-Yield Genomic DNA Kit. Universal
primers 1492R and 27F were used for the amplification of DNA
polymerase chain reaction (PCR) amplification with Applied
Biosystem Veriti R© 96-Well Fast Thermal. The PCR process
involves initial denaturation at 94◦C for 3min followed by 30
cycles of denaturation at 94◦C for 30 s, annealing at 55◦C for
30 s, extension at 72◦C for 60 and 40 s, and final extension at
72◦C for 5min. The PCR product was purified using QIA quick
PCR Purification Kit by Qiagen. Sequences of purified DNA
samples were aligned with the corresponding phylogenetic tree
constructed using MEGA6 (Tamura et al., 2013). Comparison of
16S ribosomal RNA gene sequences of the isolate was done using
EzTaxon (Chun et al., 2007).
Liquid-Liquid Partitioning of Bacterial
Isolate
The extract of the isolate contributing to highest survival of
worms was further partitioned in n-hexane, dichloromethane,
ethyl acetate, and butanol. The methanol-aqueous was mixed
with each solvent in 1:1 (v/v) ratio in a separator funnel and
shaken vigorously. The funnel was let to stand for 15min and
the resulting layers were collected and dried with a rotary
evaporator. The subsequent partitions were then employed in a
slow killing survival assay. Subsequently, the partition causing
highest percentage of worm survival was subjected to the assays
described below.
Dose Response Assay
The CF4059 worms were exposed to the infection plate as
described in the slow-killing assay with or without partition
supplementation at 50, 200, 400, and 1,000 µg ml−1 final
concentration. Worm survival was scored every 24 h.
Pharyngeal Pumping Assay
C. elegans CF4059 was exposed to the infection plates as
described in the slow-killing assay. The pharyngeal pumping
of three randomly picked worms was observed for 20 s at
12 h interval using Leica Stereomicroscope M205 FA. Pumping
rate was measured by counting grinder movement and
contraction/relaxation cycles of the bulb (Hobson et al., 2006).
Growth of P. aeruginosa PA14
Method for kinetic growth study was a modification of an earlier
protocol (Hall et al., 2014). A few PA14 colonies from 24 h freshly
cultured plates were inoculated in 250mL conical flask with
50mL Mueller-Hinton broth (Merck, Germany), followed by
incubation at 37◦C, 180 rpm for 24 h. The culture was transferred
into 50mL centrifuge tube and centrifuged at 2,775 × g for
30min. The supernatant was discarded and remaining cell pellet
was washed twice. The cell pellet was then dissolved in fresh
MH broth. The treatment well contained 10 µL of bacterial cell
culture, 180 µL of MH broth and 10 µL of 8 mg/mL extract.
Control well only contained 10 µL of bacterial cell culture and
190 µL of MH broth. The microtiter plates were incubated in the
microplate reader at 37◦C for 24 h with sampling interval every
4 h at 625 nm (BioTek Synergy Mx, USA).
PA14 Biofilm Assay
Biofilm assay was carried out as described previously (O’ Toole,
2011). PA14 was cultured in Luria Bertani (LB) broth overnight
at 37◦C with shaking at 180 rpm. PA14 was cultured in LB broth
at 37◦C with 180 rpm shaking overnight. A 96-well biofilm assay
plate with 400 µg mL−1 of actinomycete partition in LB broth
was inoculated with the overnight PA14 culture at 1:100 ratio and
further incubated overnight at 37◦C. The cells were discarded and
plate was rinsed with tap water. Biofilm formed on the wall of
the plate was stained with 1% crystal violet and solubilized with
30% acetic acid in water. Optical density was measured using
microtiter plate reader (SpectraMax M5) at 550 nm wavelength.
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PA14 Protease, Elastase Assay, and
Pyocyanin Assay
Protease and elastase assay were carried out as described
elsewhere (Rudrappa and Bais, 2008). PA14 was cultured at 37◦C
for 24 h, with or without presence of Streptomyces sp. partition
in LB broth. The supernatant was collected and filtered using
0.22µM nylon filter. About 50.0 µL supernatant was added into
the reaction mixture consisting of 0.8% azocasein (Sigma) in
500 µL of 50mM K2HPO4 at pH7. The reaction mixture was
incubated at 25◦C for 3 h. The reaction was stopped by adding
0.5mL of 1.5M HCl into the mixture. The tubes were placed on
ice for 30min and centrifuged at 7,826 × g for 10min. Finally,
0.5mL of 1M NaOH was added into the tubes and the reading
was measured at 440 nm.
For elastase assay, 50.0 µL supernatant was added to 1.0mL
of 10mMNa2HPO4 at pH7 and 20mg of elastin-Congo red. The
tubes were incubated for 4 h at 37◦C with 180 rpm shaking. The
tubes were centrifuged at 7,826 × g for 10min and the optical
density reading was taken at 495 nm.
Pyocyanin assay was carried out as described elsewhere (Essar
et al., 1990). PA14 was cultured with or without presence of
Streptomyces sp. metabolites and supernatant was collected as
above. About 4.5mL of chloroform was added to 7.5mL of
collected supernatant and vortexed for 20 s. The mixture was
centrifuged at 2,880× g for 10min. About 3.0mL of the resulting
blue layer at the bottom of the tube was transferred into a new
tube, followed by addition of 1.5mL of 0.2M HCl and vortexing
for 20 s. Tubes were then centrifuged for 2min at 2,880 × g and
1.0mL of the ensuing pink layer was transferred into cuvettes and
reading was taken at 520 nm (Thermo Scientific Genesys20).
Visualization of lys-7 in C. elegans
Slow killing assay was carried out using the transgenic lys-7::GFP
C. elegans strain SAL105. The fluorescence micrograph of worms
was captured using a Leica Microsystem M205 FA following
24 h of pathogen exposure. Images were analyzed using Image J
(National Institutes of Health, USA) to quantify lys-7 fluorescent
intensity.
Preparative TLC Fractionation
TLC plate (Merck TLC silica gel 60 F254, Germany) coated with
silica was used as the stationary phase. Sample of hexane partition
was prepared by diluting 10mg of extract in 1.0mL of CHCl3.
The sample was spotted on the plates with a capillary tube.
The plates were then put in developing chamber with solvent
system of methanol:chloroform of 20:80. After drying, a small
portion of the plate was cut, followed by staining with vanillin-
sulphuric acid reagent (Yadav and Gupta, 2013). The stained
plates were then air-dried for 15min and oven-dried at 96 ±
2◦C for 8min (Maurya and Srivastava, 2013). Spots formed were
aligned on the plate and marked. The marked area was scraped
using a scalpel. The collected fractions were dissolved in 100%
ethanol, filtered by using Whatman no.1 filter paper and rotated
to dryness. The fractions were subjected for survival assay and the
fraction with positive result was sent for GC-MS analysis (Agilent
6890, USA) with capillary column of 30m× 0.25mm× 0.25µm
(Agilent HP-5ms, USA). The flow rate was set at 1.2 mL/min,
with 10 µL sample injection. Helium gas was used and total run
was 40min. The obtained spectrum was compared with NIST
Spectral Library for compound identification.
Data Analysis
All numerical data were analyzed using GraphPad Prism 5
and StatView5.0.1 (SAS Institute, Inc) software. Values were
presented as mean ± standard deviation (SD) of at least two
independent experiments. Data from the killing assays were
analyzed with StatView 5.0.1 and plotted using the Kaplan-Meier
Cumulative Survival Plot for Time (non-parametric survival
analysis). The comparison was analyzed using the GraphPad
Prism 5 Log-rank (Mantel-Cox) significance test. Data from dose
response assay, pharyngeal pumping assay, biofilm assay, kinetic
growth of PA14 and total cell fluorescent count were analyzed
with GraphPad Prism 5 unpaired t-test.
RESULTS
Isolation of Marine Actinomycetes and
Antimicrobial Assay
A total of 18 morphologically different strains were successfully
isolated from the marine sediment samples (Table S1). These
isolates produced aerial mycelium, with four of the isolates
showing pigmentation. All isolates produced mycelial clump
when cultured in broth medium after incubation in shaker at 180
rpm and 28 ± 2◦C. All 18 isolates were extracted and subjected
to anti-microbial assay. None of these isolates caused a visible
inhibition zone on the P. aeruginosa PA14 lawn (data not shown)
which means these extracts do not possess bactericidal activities
toward PA14.
Effect of Marine Actinomycetes Methanol
Extracts and Partitions on Survival of PA14
Infected C. elegansWorms
Compared to untreated PA14 infected worms, infected worms
treated with 8 of the 18 marine actinomycetes extract,
respectively, (A3, A5, A22, A26, A38, A42, A48, and A50) showed
improved survival rates (Figure 1). Among these, statistically
significant increase in survival rate was achieved with A3, A5, and
A22 (36.99 ± 2.80–57.31 ± 3.85%), with isolate A5 contributing
to the highest survival rate. In tandem, A5 also delayed mortality
of infected worms, as represented in TD50 value (Table S2).
In addition, worms treated with the remaining extracts (A20,
A24, A30, A31, A39, A40, A41, A43, A45, and A47), showed
increased susceptibility to killing by PA14. Further partitioning
of the isolate A5 methanol extract followed by slow killing assay
revealed the hexane partition of isolate A5 to be most potent in
attenuating the killing of infected worms, with survival rate of
69.65± 4.50% (Figure 2) and TD50= 102.2± 5.54 h (Table S3).
A5 Isolate Identified as Streptomyces sp.
CCB-PSK207
Using partial 16S analysis, the A5 isolate showed sequence
identity of 99.7–99.85% with several Streptomyces sp.
This include Streptomyces sundarbansensis, Streptomyces
puniceus, Streptomyces badius, Streptomyces sidensis,
Streptomyces rubiginosohelvolus, Streptomyces pluricolorescense,
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FIGURE 1 | Survival of C. elegans infected with Pseudomonas aeruginosa
PA14 in the presence of marine actinomycetes crude methanolic extract. A5
crude methanolic extract resulted in significantly highest C. elegans survival
during the PA14 killing assay. *Denotes significance in the Log-rank test in
comparison to the untreated control (p < 0.05). Data were representative of
two independent experiments.
FIGURE 2 | Survival of C. elegans infected with Pseudomonas aeruginosa
PA14 in the presence of different portion of A5 isolate. Hexane partition of the
A5 methanolic extract resulted in significantly highest C. elegans survival
during PA14 killing assay. *Denotes significance in the Log-rank test in
comparison to the untreated control (p < 0.05). Data were representative of
three independent experiments.
Streptomyces parvus, Streptomyces globisporus, and Streptomyces
cyaneofuscatus (Figure 3). The sequence was deposited in NCBI
GenBank under accession number KX372372. On ISP2 agar
plates, A5 isolate produced white beige aerial mycelia and
brownish substrate mycelia with no pigmentation (Figure S1).
A5 isolate was named as Streptomyces sp. CCB-PSK207.
Effect of Streptomyces sp. CCB-PSK207
Hexane Partition on Survival of
PA14-Infected C. elegans
Results showed that the hexane partition of the Streptomyces sp.
CCB-PSK207 extract promoted survival of PA14-infected worm
in a dose dependent manner with a gradual increase observed
from 45.33 ± 4.32 to 72.71 ± 4.66% at concentration range of
50–400 µg mL−1(Figure 4). There was no further increase in
C. elegans survival promotion at 1,000 µg mL−1 concentration.
Effect of Streptomyces sp. CCB-PSK207
Hexane Partition on C. elegans Feeding
Activities
Comparison of pharyngeal pumping rate in C. elegans exposed to
the Streptomyces sp. CCB-PSK207 hexane partition with worms
without presence of partition showed no significant difference
for all three time points (Figure 5). This indicated that the
Streptomyces sp. CCB-PSK207 hexane partition did not interrupt
C. elegans feeding rate.
Effect of Streptomyces sp. CCB-PSK207
Hexane Partition on PA14 Growth
Similarly, the Streptomyces sp. CCB-PSK207 hexane partition
did not impair growth kinetics of PA14, which denote that the
rescue of PA14 infected worms did not occur through killing of
pathogens (Figure 6).
Effect of Streptomyces sp. CCB-PSK207
Hexane Partition on PA14 Virulence Factor
Production
Results showed no significant difference in the level of biofilm,
protease, and pyocyanin production between control PA14 and
those exposed to Streptomyces sp. CCB-PSK207 hexane partition
(Figure 7). However, a significant increase in elastase production
was observed in treated PA-14.
Effect of Streptomyces sp. CCB-PSK207
Hexane Partition on the Expression of lys-7
in PA14 Infected C. elegans
As compared to worms fed with E. coli OP50, PA14-infected
worms showed diminished fluorescent signal (Figures 8A,B).
However, treatment with Streptomyces sp. CCB-PSK207 hexane
partition appear to restore GFP expression in both PA 14
infected worms and OP50 fed worms (Figures 8C,D). Imaging-
based software quantification showed that worms exposed to
Streptomyces sp. CCB-PSK207metabolites produced significantly
highest intensity of GFP expression (Figure 8E).
Effect of Streptomyces sp. CCB-PSK207
Fraction on Survival of PA14-Infected
C. elegans
Three fractions were collected from preparative TLC and further
employed in the C. elegans slow killing survival assay. Among
them, fraction A5HB showed a significant increase in worm
survival rate at 71.43 ± 4.67% (Figure 9) and TD50 of 93.6
± 1.9 h (Table S4). Fraction A5HA resulted in <20% worm
survival, while A5HC increased the susceptibility of worms
toward mortality caused by PA14, respectively.
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FIGURE 3 | Tamura-Nei model of phylogenetic tree. Tree based on 16S rRNA gene sequences obtained by the Neighbor Joining (NJ) method showing the position of
A5 isolate among its phylogenetic neighbors. Numbers at nodes indicate levels of bootstrap support (%) based on a NJ analysis of 1,000 resampled datasets.
FIGURE 4 | Streptomyces sp. CCB-PSK207 hexane partition promotes
survivability of PA14-infected worms in a dose dependent manner.
Concentration of 400 µg mL−1showed the highest percent survival of the
worms compared to the untreated control. *(p<0.05) and **(p< 0.01) denotes
statistically significance in Dunnett’s test in comparison to the untreated
control. Data were representative mean ± SD of three independent screenings
at 96 h’ time point.
Chemical Profiling of Streptomyces sp.
CCB-PSK207 A5HB Fraction
Further chemical profiling and compound identification was
done using GC-MS (Pollak and Berger, 1996). Seven main
compounds were identified, Figure S2 namely (1) tetradecanoic
acid methyl ester, (2) pentadecanoic acid 14-methyl methyl ester,
(3) tetradecanoic acid, 12-methyl-methyl ester, (4) tridecanoic
acid methyl ester, (5) hexadecanoic acid methyl ester (6)
octadecanamide, and (7) 1,2-benzenedicarboxylic acid mono(2-
ethylhexyl) ester (Table 1).
FIGURE 5 | Streptomyces sp. CCB-PSK207 hexane partition does not impair
C. elegans feeding activities. There is no distinguishable difference observed in
the pumping rate count between the extract-treated and control worms at the
indicated time points (t-test, p-value of 1.00, 0.392, and 1.00 at 0, 12, and
24 h time-points, respectively). Representative result is depicted from three
independent experiments and values are expressed in mean ± SD.
DISCUSSION
Given the multiple health hazards posed by P. aeruginosa and
the rise of multi-drug resistant strains, it is essential that novel
drugs with anti-infective properties are discovered (Hauser and
Sriram, 2005). Marine actinomycetes are a promising target, as
exemplified by consistent discovery of promising metabolites
against fungal, parasitic, bacterial, and viral diseases (Rahman
et al., 2010; Subramani and Aalbersberg, 2012; Manivasagan
et al., 2013). The C. elegans-PA14 slow killing assay has been
employed to search for potential immune-boosting metabolites
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FIGURE 6 | Streptomyces sp. CCB-PSK207 hexane partition did not impair
PA14 growth at 400 µg mL−1. Data were analyzed with unpaired t-test,
p = 0.917. Data are expressed in mean ± SD. Experiments carried out in
three independent experiments
FIGURE 7 | Production of PA14 virulence factor upon treatment with
Streptomyces sp. CCB-PSK207 hexane partition. There is no distinguishable
difference in the production level of biofilm formation (p = 0.0530), protease
(p = 0.0540), and pyocyanin (p = 0.0735) between extract-treated and control
worms. Significant increase in elastase production level were observed
following extract treatment (p = 0.0424). All the assays were carried out in
three independent experiments. Results are expressed in mean ± SD. Data
were analyzed with one sample t-test where **denotes statistically significance
(p<0.01) in comparison to the untreated control.
(Adonizio et al., 2008b; Zhou et al., 2011; Durai et al., 2013;
Li et al., 2014). We report here the use of this assay to
screen marine actinomycetes for anti-infective properties against
P. aeruginosa.
We first showed that the actinomycetes extracts did not
directly inflict mortality on PA14. This will rule out the
detection of compounds with bactericidal effects and divert
subsequent discovery to isolation of lead compounds targeting
immunity of host or virulence of pathogen. Using the slow
killing assay, we discovered a partition from the methanol
extract of an actinomycetes isolated from sea sediment which
significantly boost the survival in PA14-infected worms in a
dose dependent manner. This increase is comparable to level
of survivals observed in PA14 infected worms treated with
Swietenia macrophylla seed extract (Dharmalingam et al., 2012)
and curcumin (Rudrappa and Bais, 2008). Using 16S analysis,
this isolate was shown to have >99.5% identity with several
Streptomyces sp. and was designated as Streptomyces sp. CCB-
PSK207. Among all actinomycetes, the Streptomycetes group
is economically valuable, giving rise to 50–55% of known
antibiotics (Bérdy, 2005). However, only a small portion of
marine actinomycetes have been subjected for bioprospecting
of new therapeutics. Besides efficacy, having the host in the
screening assay provides an added advantage of early indication
of compound toxicity (Squiban and Kurz, 2011). This could
plausibly explain the higher mortalities encountered by worms
exposed to several of the crude methanol extracts in this present
study.
Slow killing of C. elegans by PA14 involves the colonization
and proliferation of pathogen in the host gut (Tan et al.,
1999a). As such, it is important to establish if Streptomyces
sp. CCB-PSK207 metabolites mitigate killings by diminishing
gut colonization in worms. Since the colonization of PA14 in
nematode gut commence with feed intake, a reliable indicator is
observation of the pumping rate of C. elegans pharynx, a tube
involved in feeding and transportation of bacteria into the gut
(Avery and Shtonda, 2003). Overall, our results showed that PA14
exposed to Streptomyces sp. CCB-PSK207 partition could still
grow and colonize gut of host after feeding. These observations
were also reported with anti-infective natural products isolated
from a similar screening approach (Rudrappa and Bais, 2008;
Dharmalingam et al., 2012; Durai et al., 2013; Kong et al.,
2014a,b).
A plausible scenario to explain the improved survival of
infected worms treated with the bioactive partition is the
presence of compounds with anti-virulence activities. The
widespread problems associated with PA14 is principally due
to the production of a series of virulence factors including
protease, elastase, pyocyanin, and alginate (Lyczak et al., 2000).
In addition, formation of obdurate biofilms is a crucial armory in
PA14’s persistency against antimicrobial therapy (Ma et al., 2009).
During PA14 infection of C. elegans, the pathogens produce
virulence-related membrane vesicles, leading to the accretion of
biofilm-likematerial on host intestinal cells (Irazoqui et al., 2010).
There have been several reports on natural product-based small
molecules from marine organisms, including actinomycetes
showing potency against virulence of PA14 (Hentzer et al., 2003;
Fu et al., 2013; Naik et al., 2013; Yaniv et al., 2017). Our results
showed that Streptomyces sp. CCB-PSK207 hexane partition
did not subdue production of biofilm, protease, and pyocyanin
in PA14. This supports our earlier observation of normal gut
Frontiers in Microbiology | www.frontiersin.org 7 November 2017 | Volume 8 | Article 2267
Fatin et al. Marine Actinomycete against P. aeruginosa Infection
A B C D
E
FIGURE 8 | Induced expression of lys-7 in PA14 infected worms upon treatment with Streptomyces sp. CCB-PSK207 hexane partition. Representative fluorescence
micrographs of worms after 24-h incubation with partition. (A) Worms fed on OP50, uninfected; (B) PA14-infected worms without extract treatment and (C)
PA14-infected worms treated with 400 µgmL−1 hexane extract; (D) worms fed on OP50 and treated with 400 µgmL−1 hexane extract, uninfected. Worms were
examined under Leica Microsystem M205 FA with magnification x127. “+” denotes anterior head region of the worms. (E) Corrected total cell fluorescence of lys-7
micrograph A, B, C, and D. Data were analyzed with the Image J software version 1.49. **Denotes significance (p<0.01, t-test) in comparison to the untreated control.
FIGURE 9 | Survival of C. elegans infected with Pseudomonas aeruginosa
PA14 in the presence of different fractions in the killing assay. Fraction A5HB
significantly promotes C. elegans survival during PA14 killing assay. *Denotes
statistically significance in the Log-rank test in comparison to the untreated
control (p < 0.05). Data were representative of two independent experiments.
colonization in nematode exposed to the bioactive extract as
PA14mutants with perturbed quorum sensing cascade are unable
to colonize the gut of C. elegans (Tan et al., 1999b). Extracts of
several terrestrial and aquatic plant species, have been reported
to rescue C. elegans from mortality by interfering with PA14
quorum sensing and virulence activities (Adonizio et al., 2008a,b;
Rudrappa and Bais, 2008; Kandasamy et al., 2012; Husain
et al., 2013; Liu et al., 2013; Sarabhai et al., 2013). Therefore, a
disparity between these chemical entities and Streptomyces sp.
CCB-PSK207 is that the latter did not seemed to rescue PA14
infected worms through disruption of pathogen virulence factors.
Elsewhere, similar to our results, selenite did not reduce both
quorum-sensing signals and virulence factors of PA14 but was
able to promote C. elegans survival (Li et al., 2014). Elastase
or lasB is a metalloproteinase secreted by P. aeruginosa, with
multiple roles leading toward cytotoxicity and degradation of
host immune system (Kipnis et al., 2006). C. elegans exposed
to LasB-knockout PA14 survived longer as compared to the
normal virulent PA14 strain in the slow killing assay (Zhu et al.,
2015). Intriguingly, our results demonstrate that actinomycete
extract resulted in an increase of elastase production. Elsewhere,
fatty acids have been shown to stimulate levels of elastase in
P. aeruginosa (Kwan et al., 2011). Despite the increased levels
of elastase produced by PA14 in presence of the actinomycete
extract, it is worth noting that this did not translate to higher
worm kills.
C. elegans possess 10 lysozyme-like proteins (lys-1 to lys-10),
with several of them associated with host defense (Mallo et al.,
2002). Among these, lys-7 have been shown to be immune-
specific, with RNAi mediated lys-7 knockdown worms showing
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TABLE 1 | Compounds identified from fraction A5HB using GC-MS.
No. Retention time (min.) Compound Formula Molecular weight (MW) Quality (%)
1 9.37 Tetradecanoic acid methyl ester C15H30O2 242 96
2 9.93 Pentadecanoic acid 14-methyl-methyl ester C16H32O2 256 94
3 9.97 Tetradecanoic acid 12-methyl-methyl ester C16H32O2 256 89
4 10.45 Tridecanoic acid methyl ester C14H28O2 228 96
5 10.64 Hexadecanoic acid methyl ester C17H34O2 270 96
6 11.29 9-octadecanoic acid methyl ester C19H36O2 296 60
7 13.60 1,2-benzenedicarboxylic acid mono(2-ethylhexyl) ester C16H22O4 278 90
Chemical profile of compounds was compared with NIST spectral library.
increased sensitivity to pathogen killing (Mallo et al., 2002;
Nandakumar and Tan, 2008; Simonsen et al., 2011). It has
been reported that PA14 suppresses C. elegans immunity by
repressing the expression of lys-7 (Evans et al., 2008). Our
results showed that the hexane partition of Streptomyces sp.
CCB-PSK207 boosted the level of lys-7 which was weakened
during PA14 infection. Restoration of repressed lys-7 during
infection have also been reported with other single compounds
and plant extracts (Dharmalingam et al., 2012; Kong et al.,
2014a; Li et al., 2014). Concomitantly, uninfected worms treated
with Streptomyces sp. CCB-PSK207 partition also showed an
increase expression of lys-7, giving direct evidence of the presence
of bioactive compounds capable of inducing lys-7. Taking into
consideration that PA14 compromise host immunity through the
suppression of various host defense molecules including lys-7,
our results indicate that the bioactive partition have the capacity
to restore this deficiency, leading to a rescue from mortality
(Evans et al., 2008). While numerous reports of compounds
attenuating PA14 virulence have been isolated from marine
actinomycetes, to our knowledge, this is the first report of marine
actinomycete metabolites inducing immunity in an infected host.
A possible outcome of the induced elastase levels in PA14 in
presence of the actinomycete extract is the reciprocal increase in
innate immune response of host, as seen in insects (Andrejko
and Mizerska-Dudka, 2011). Therefore, besides inducing lys-
7 as the defense molecule during infection, we do not rule
out the possibility of an alternate stimulus of innate immunity
caused by higher elastase production by PA14. A slow killing
assay involving infection of C. elegans with LasB-knockout
PA14 will be useful to endorse this possible route (Zhu et al.,
2015).
GC/MS analysis of the Streptomyces sp. CCB-PSK207
bioactive fraction showed the presence of methyl esters
of several saturated fatty acids including tridecanoic acid,
tetradecanoic acid, and hexadecanoic acid. Simultaneously,
methyl esters of branched-chain tetradecanoic acid, 12-methyl
and pentadecanoic acid 14-methyl were also present. Some of
these fatty acids have previously been reported from Streptomyces
sp. (González et al., 2005; Ser et al., 2016). Methyl ester
of tridecanoic acid, tetradecanoic acid, hexadecanoic acid,
pentadecanoic acid 14-methyl, and tetradecanoic acid 12-methyl
have also been reported in C. elegans (Henry et al., 2016).
Although the actual mechanism by roles these compounds
protect C. elegans from PA14-induced mortality is still unclear,
some hints as to their possible functions could be derived from
literature pertaining to C. elegans immunity and fatty acids. Two
18 carbon unsaturated fatty acids, gamma-linolenic acid (GLA,
C18:3n6) and stearidonic acid (SDA, C18:4n3) are pivotal for
C. elegans defense against PA14 infection as these fatty acids
regulate basal expression of immune-specific genes including
lys-7 (Nandakumar and Tan, 2008). Interestingly, hexadecanoic
acid methyl ester can be elongated endogenously by worms
to stearic acid (C18:0), followed by further desaturation to
generate GLA or SDA, which could speculatively restore lys-7 in
PA14 infected worms (Watts and Browse, 2002). Elsewhere,1,2-
benzenedicarboxylic acid mono (2-ethylhexyl) ester (MEHP) is
also reported to induce the activation of the mitogen-activated
protein kinase p38 (p38 MAPK) pathway, a pivotal signaling
mechanism in C. elegans innate immunity (Kim et al., 2002;
Rakkestad et al., 2010). Obliteration of nhr-49, a known master
regulator of lipid metabolism in C. elegans also resulted in higher
susceptibility to pathogenic infection, giving indication to the
importance of fatty acids and C. elegans innate immunity (Sim
and Hibberd, 2016).
In conclusion, this present study revealed the rescue of
PA14-infect C. elegans by metabolites from a locally isolated
Streptomycetes species. We also showed that this process
circumvented bactericial or anti-virulences mechanisms and
instead, induced worm immunity. Lastly, we showed that
the bioactive molecules responsible for these observations are
fatty acid methy-esthers which could hypothetically stimulate
expression of lys 7.
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